MTV NEWS ARTICLES

AUTHOR: Hilary Allan
11/10/2017
1:24 pm
TAGS: ,

Eminem‘s long-awaited comeback is finally happening this weekend at the 2017 EMA in London! The notorious Rap God will be performing his new single “Walk On Water” live for the first time on Sunday night.

It’s been four years since Eminem performed¬†“Berzerk” and “Rap God” and was honored with the Global Icon Award at the 2013 EMA.

Eminem’s going to be releasing his ninth album soon and rumors have been circulating about it for months now. The upcoming album still remains a big mystery on many fronts including the release date. This EMA performance will finally give fans a taste of the new album!

Eminem has been dropping major hints about the album on Instagram and confirmed a rumor that it will be called Revival.

A post shared by Marshall Mathers (@eminem) on

The especially intriguing rumor about the album’s title started with an Instagram post from Eminem’s trusted manager, Paul Rosenberg. The photo he shared featured a suspiciously prominent advertisement for a prescription drug called “REVIVAL” in the background. Fans quickly spotted Eminem’s signature backwards ‘E’ in the drug’s name, did some digging and discovered that the disease that the drug claims to treat doesn’t exist.

Look what arrived at the Shady offices today! @Yelawolf TRIAL BY FIRE comes out this Friday 10/27! #cdbaby

A post shared by Paul Rosenberg (@rosenberg) on

REVIVAL’s website, askaboutrevival.com, has a number of red flags. At first glance, it seems like your typical boring prescription drug website but when you look at the details it starts to sound a lot like Eminem. Symptoms listed on the site include “highly combustible head,” “rage” and “male pattern baldness (most commonly in women).” The video on the site includes the line, “It’s easy to lose yourself.” Lose yourself, people! So, yeah, it’s hard deny that Eminem is behind it.

His performance is going to be a memorable addition to an already incredible lineup that includes Kesha, Shawn Mendes, Demi Lovato and more.

Comments